BeyondSpring Announces First Quarter 2021 Financial Results and Provides a Corporate Update

NEXT STORY
BriaCell Therapeutics Expands Breast Cancer Platform Technology into Prostate, Melanoma, and Lung Cancers
PREV STORY
Paratek Pharmaceuticals Announces Initiation of Phase 2b Study in Nontuberculous Mycobacterial (NTM) Pulmonary Disease Caused by Mycobacterium abscessus Complex (MABc) with NUZYRA® (omadacycline)
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Targovax Receives 2017 Nordic Stars Award

Oslo, Norway, 14 September 2017: Targovax ASA ("Targovax" or "the Company"; OSE: TRVX), a ...

author_avatar
NASDAQ Market News

Vital Therapies Appoints Former Receptos President and CEO Faheem Hasnain as Chairman of the Board of Directors

SAN DIEGO, Sept. 06, 2017 (GLOBE NEWSWIRE) -- Vital Therapies, Inc. (Nasdaq:VTL), a biotherapeutic ...

author_avatar
NASDAQ Market News

World’s Top Lyme Disease Scientists, Researchers Coming to Colorado at Invitation of 13-Year-Old Advocate

Local Foundation Hosts First LivLyme Summit September 22-23Denver, Colo., Aug. 16, 2018 (GLOBE NEWSWIRE) ...

author_avatar
NASDAQ Market News